Sort by
Refine Your Search
-
(nano)hormone-chemotherapy strategy for hormone-dependent breast cancers expressing the HER2 receptor (HR+HER2+). These cancers are associated with poor prognosis and high mortality and account for
-
enhanced performance. These advancements will facilitate the creation of smaller, faster, and more adaptable systems for next-generation computing applications. Working with consortium partners
-
://meeresearch.weebly.com/ Further information on the other projects within the consortium can be found on Euraxess. Selection criteria Applicants must not already hold a doctoral degree at the date of recruitment
-
the physical fitness and psychological profile essential for the performance of the duties, and have complied with mandatory vaccination requirements, as set out in Article 17 of the LTFP; Hold a doctoral degree
-
essential for the performance of the duties, and have complied with mandatory vaccination requirements, as set out in Article 17 of the LTFP; Hold a doctoral degree awarded by a Portuguese or foreign higher
-
analyses; • characterising the obtained nanomaterials using analytical techniques such as UV-Vis spectroscopy, high-performance liquid chromatography (HPLC) and dynamic light scattering (DLS